In MM, the Descartes-08 program (NCT03448978 (163),) evaluated ex vivo-transfected anti-BCMA CAR-T cells in a small Phase I cohort (<20 patients). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.